AMGEN INC., et al v. XAVIER BECERRA, et al

description

Case Summary

AMGEN INC. and other pharmaceutical companies have filed a lawsuit against Xavier Becerra, the California Attorney General, and other state officials. The lawsuit challenges a California law that requires pharmaceutical companies to disclose certain information about their pricing and business practices. The plaintiffs argue that the law is unconstitutional and violates federal law.

Latest development

1:24-cv-03571 AMGEN INC., et al v. XAVIER BECERRA, et al

Motion · April 24, 2026

A Motion was filed.

description View filing

Key Issues

• • Constitutionality of California law
• • Federal preemption
• • Pharmaceutical pricing transparency

smart_toy Juryvine case summary generated from primary court records. How we verify our work.

update What Changed This Week

1 event

edit_note

Motion 2 days ago

A Motion was filed.

receipt_long Source (filing) expand_more

Memorandum in opposition to motion ( 37

Open original open_in_new

Juryvine summaries are generated from court records. Expand "Source" on any row to see the underlying filing.

Case Timeline

1 event

edit_note

Motion April 24, 2026

1:24-cv-03571 AMGEN INC., et al v. XAVIER BECERRA, et al

A Motion was filed.

description View filing open_in_new

newspaper

Press Coverage

1 article

All No paywall (1) Original reporting (1)

newspaper

Coverage

1:24-cv-03571 AMGEN INC., et al v. XAVIER BECERRA, et al

Memorandum in opposition to motion ( 37

Apr 24, 2026 · 1 min read